ANI Pharmaceuticals | ANIP - Trade Debtors


ANI Pharmaceuticals reported $255.43M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
ANI Pharmaceuticals USD 255.43M 25.65M Mar/2026
Assertio Holdings USD 39.91M 2.7M Jun/2024
Aurora Cannabis CAD 48.26M 1.53M Dec/2025
Canopy Growth CAD 140.42M 113.56M Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Omeros USD 8.08M 440K Jun/2024
Perrigo USD 697.1M 84.3M Mar/2026
Sun Pharmaceuticals INR 157.04B 26.1B Sep/2025
Teva Pharmaceutical Industries USD 3.39B 316M Mar/2026